Chi‐Yi Chen

机构：Kaohsiung Medical University, National Taiwan University, Kaohsiung Medical University Chung-Ho Memorial Hospital, Mackay Memorial Hospital, Chia-Yi Christian Hospital, National Taiwan University Hospital, Hepatitis B Foundation, National Defense Medical Center

发表论文 33 篇 · 总被引 580 次 · h-index 11

代表论文

Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients (2016 · Liver International · 被引 225)
Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in Taiwan (2021 · Liver International · 被引 57)
Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan (2018 · Alimentary Pharmacology & Therapeutics · 被引 52)
A phase 2, open‐label, randomized, multiple‐dose study evaluating Inarigivir in treatment‐naïve patients with chronic hepatitis B (2022 · Liver International · 被引 29)
Declining trends of prevalence ofHelicobacter pyloriinfection and incidence of gastric cancer in Taiwan: An updated cross‐sectional survey and meta‐analysis (2022 · Helicobacter · 被引 27)
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis‐related complications (Taiwanese chronic hepatitis C cohort) (2021 · Journal of Gastroenterology and Hepatology · 被引 23)